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The N-end rule relates the in vivo half-life of a 
protein  to  the identity of its N-terminal  residue. In the 
yeast Saccharomyces  cereuisiae, substrates  of  the  N- 
end rule pathway are targeted for degradation by a 
complex that includes the 225-kDa N-recognin, en- 
coded  by UBRl,  and  the 20-kDa ubiquitin-conjugating 
enzyme  encoded  by UBC2. We report  that  both physi- 
cal stability and  functional activity of  the  N-recognin 
Ubc2  complex  require  the  presence  of  a  highly  acidic 
23-residue region at the C terminus of Ubc2. Ubc2- 
C88A, an inactive variant  of  Ubc2  in  which  the active- 
site Cys-88 has  been  replaced  by  Ala, is shown  to  retain 
the affinity for  N-recognin.  Expression of Ubc2-CSSA 
inhibits  the  N-end rule pathway,  apparently as a  result 
of  competition  between  Ubc2  and TJbc2-CSSA for  bind- 
ing to  N-recognin.  The  two-hybrid  (interaction  clon- 
ing) technique was used  to identify a -170-residue C- 
terminal  fragment  of  the 1,950-residue N-recognin as 
a Ubc2-interacting domain. We also  show  that  the level 
of UBRl mRNA decreases upon overexpression of 
UBC2. This effect of UBC2 is observed with cells 
whose UBRl is expressed  from  an  unrelated  promoter 
but is not observed if UBRl contains a frameshift 
mutation, or if  the  Ubc2  protein lacks its C-terminal 
acidic  region.  The  N-recognin Ubc2  complex  appears 
to regulate  the  expression  of  N-recognin  through 
changes  in  the  metabolic stability of its mRNA. 
Among the functions of intracellular proteolysis are the 
elimination of abnormal  proteins  and the temporal  control of 
many cellular processes that involve short-lived regulators. 
Amino  acid sequences, conformational determinants,  or 
chemically modified protein  structures  that confer metabolic 
instability are called degradation signals, or degrons (Var- 
shavsky, 1991). An essential component of one degradation 
signal is the protein’s N-terminal residue (Bachmair et al., 
1986). The presence of this signal, the N-degron, is manifested 
as the N-end rule, which relates the in vivo half-life of a 
protein to  the identity of its N-terminal residue (reviewed by 
Varshavsky, 1992). Distinct versions of the N-end rule operate 
in  all organisms examined, from mammals to yeast and bac- 
teria (Bachmair et al., 1986; Gonda et al., 1989; Tobias et al., 
1991). 
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The eukaryotic N-degron comprises at least two determi- 
nants:  a destabilizing N-terminal residue and an internal Lys 
residue (or residues) (Bachmair  and Varshavsky, 1989; John- 
son et al., 1990; Dunten et al., 1991). The  latter is the site of 
attachment of a multiubiquitin (multi-Ub)  chain whose for- 
mation is required for the degradation of at least some N-end 
rule substrates. In a multi-Ub chain, several ubiquitin (Ub)’ 
moieties are attached sequentially to an acceptor protein, 
forming a  chain of Ub-Ub conjugates in which the C-terminal 
Gly-76 of one Ub is joined to Lys-48 of the adjacent Ub (Chau 
et al., 1989; Johnson et al., 1992). A substrate that bears  a 
multi-Ub  chain is degraded by the 26 S proteasome, a -1,500 
kDa, ATP-dependent, multicatalytic protease that contains 
more than 20 distinct  subunits. Different Ub-dependent path- 
ways are mediated by distinct  targeting complexes  while ap- 
parently  sharing at least  a  protease component (the 20 S or 
“core” proteasome) (reviewed by Finley and Chau, 1991; 
Rechsteiner, 1991; Hershko and Ciechanover, 1992;  Goldberg, 
1992; Hochstrasser, 1992; Varshavsky, 1992). 
In the yeast Saccharomyces  cerevisiae, the recognition com- 
ponent of the N-end rule pathway, called N-recognin (it is 
also known as E30 (Hershko and Ciechanover, 1992)), is 
encoded by the UBRl gene (Bartel et al., 1990). The 225-kDa 
N-recognin (Ubrl) selects potential  N-end rule substrates by 
binding to their primary destabilizing N-terminal residues 
Phe, Leu, Trp,  Tyr, Ile, Arg,  Lys, and His. N-recognin has at 
least two substrate-binding sites. The type 1 site is specific 
for the basic N-terminal residues Arg, Lys, and His. The type 
2 site  is specific for the bulky hydrophobic N-terminal resi- 
dues Phe, Leu, Trp,  Tyr,  and Ile (Reiss et al., 1988; Gonda et 
al., 1989; Baker and Varshavsky, 1991). These N-terminal 
residues are bound directly by N-recognin, whereas secondary 
destabilizing N-terminal residues (Asp and Glu in yeast) 
function through their conjugation, by Arg-tRNA-protein 
transferase  (R-transferase), to Arg, one of the primary desta- 
bilizing residues. Tertiary destabilizing N-terminal residues, 
Asn and Gln, function through  their conversion, by a specific 
amidase, into  the secondary destabilizing residues Asp and 
Glu (Gonda et al., 1989; Balzi et al., 1990;  reviewed  by Var- 
shavsky, 1992). 
In S. cerevisiae, the ubiquitination of N-end rule substrates 
has been found to require the Ub-conjugating enzyme encoded 
by the UBC2 gene (its old name is RADG), and Ubc2 has been 
shown to be physically associated with N-recognin (Dohmen 
et al., 1991a). The yeast Ubc2 can also function  as an N-end 
rule-mediating Ub-conjugating enzyme in a heterologous cell- 
free system such as an extract from rabbit reticulocytes (Sung 
et d . ,  1991).  Ubc2 is one of at least 10 distinct Ub-conjugating 
~~ 
The abbreviations used are: Ub, ubiquitin; Nt-amidase, N-termi- 
nal amidase; kb, kilobases or kilobase pairs; @gal, E. coli 8-galactosid- 
ase; Ub-X-@gal, ubiquitin-X-@gal, where X is an  amino acid residue 
at  the Ub-@gal junction; PAGE, polyacrylamide gel electrophoresis; 
XGal, 5-bromo-4-chloro-3-indolyl-@-~-galactopyranoside; ha, hemag- 
glutinin. 
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enzymes (also called E2 enzymes) in S. cereuisiae (Jentsch et 
al., 1987; reviewed by Jentsch, 1992). The E2 enzymes use 
activated Ub, produced  by the Ub-activating (El)  enzyme, to 
catalyze the formation of isopeptide bonds between the C- 
terminal Gly-76 of ub and c-amino groups  of lysines in 
acceptor  proteins  (reviewed  by Pickart, 1988; Finley and 
Chau,  1991; Jentsch, 1992). 
Processes that are  known to be  perturbed  by mutations in 
UBC2 include DNA repair, induced mutagenesis, cell cycle 
control, sporulation,  regulation of retrotransposon transposi- 
tion, and the N-end rule pathway of protein degradation 
(Reynolds et al., 1985; Borts et al., 1986; Friedberg, 1888 
Picologlou et al., 1990;  Madura et al., 1990; Ellison et al., 1991; 
Kang et al., 1991; Dohmen et al., 1991a,  and  references 
therein). The N-end rule  pathway is inactive in either a ubc2 
or a ubrl null  mutant;  however, the overall ubc2 phenotype is 
more  severe than that of ubrl, indicating that the functions 
of the ubc2 enzyme are not confined to the N-end rule 
pathway (Dohmen et al., 1991a). 
While it is  likely that most of the E2 enzymes  in yeast and 
other  eukaryotes  are  guided to their in vivo substrates by E2- 
associated "recognition" subunits (recognins) (Varshavsky, 
1992), the yeast N-recognin . ubc2 complex  remains the only 
example of such an assembly that has  been  defined geneti- 
cally. A further biochemical and genetic dissection of this 
complex is described  below. 
EXPERIMENTAL PROCEDURES 
Strains, Media, Genetic Techniques, and @-Galactosidase Assay- 
The S. cereuisiae strains used in this work are listed in  Table I. 5'. 
cereuisiue were grown at 30 "C in rich (YPD) or synthetic media 
(Sherman  et al., 1986), with the  latter containing  either 2% dextrose 
(SD medium), 3% galactose (SG medium), or 3% raffinose (SR 
medium). Transformation of S. cereuisiae was carried out by the 
methods of Dohmen et al. (1991b) or Schiestl and Gietz (1989). 
Enzymatic activity of @gal in  extracts from yeast cultures  in expo- 
nential growth (Am < 1) was measured using the o-nitrophenyl-0-D- 
galactoside assay as described by Baker and Varshavsky (1991). 
Plasmid Construction-Standard methods were used (Ausubel et 
al., 1989). DNA fragments were isolated from agarose gels using 
Geneclean (BiolOl, La Jolla, CA). The high copy (2 p-based) plasmid 
pADHUBC2 which expressed Ubc2 from the strong P ~ H ~  promoter 
was constructed using the vector YEplacl95 as described in Dohmen 
et al. (1991a). The analogous plasmids pJD647, pJD617, pJD616, and 
pJD615 that expressed, respectively, Ubc2-C88A, Ubc2-164, Ubc2- 
153, and Ubc2-149 from the P ~ H ~  promoter were constructed by 
inserting  these mutant alleles of  UBC2, contained  in EcoRI fragments 
from plasmids pR647 (Sung et al., 1990), pR617, pR616, and pR615 
(Morrison et al., 1988) (gifts from L. Prakash, University of Roches- 
ter, NY), into EcoRI-cut YEplacl95ADH (Dohmen et al., 1991a). 
The plasmid pKM1167 that expressed UBC2 from the galactose- 
inducible Peal promoter was constructed by first isolating a -0.6-kb 
BamHI-EcoRI fragment of pG12 (Nicolet and Friedberg, 1987) that 
contained the P G ~ ~ ~ , G A L ~ ~  promoter region, blunting the fragment's 
ends with Klenow PolI, and ligating the fragment into  the  SmaI-cut, 
low copy (CEN-based) plasmid YCplac33 (Gietz and Sugino, 1988), 
yielding pKM1035. A -0.6-kb fragment of pDG309-containing UBC2 
(a gift from R.  D. Gietz, University of Manitoba, Winnipeg, Canada) 
was then ligated into EcoRI-cut pKM1035, yielding pKM1167. The 
ubc2-148 allele of UBC2, used in UBC2-UBRl coexpression experi- 
ments (Fig. 4), was constructed from UBC2 using polymerase chain 
reaction and synthetic oligodeoxynucleotides (Ausubel et al., 1989). 
The polymerase chain reaction-produced fragment  containing ubc2- 
148 was ligated into EcoRI-cut pKM1035, yielding pKM1166. 
To express UBRl from the copper-inducible Pcupl promoter, we 
modified the high copy plasmid pJD1003, a derivative of pSOB35 
that encoded Ubrl  and contained a unique Sal1 site (produced by 
site-directed mutagenesis) 15 base pairs  upstream of the  start (ATG) 
codon of UBRZ? This plasmid was digested with PstI and EspI, 
treated with T4 DNApolymerase, and self-ligated, yieldingpKM1307, 
which lacks a 5'-proximal portion of the QCR9 gene that was present 
R. J. Dohmen, B. Bartel, and A. Varshavsky, unpublished data. 
in our earlier UBRI-expressing plasmids. QCR9, located next to 
UgRl on Chromosome VII, encodes subunit  9 of the mitochondrial 
ubiquinol-cytochrome c oxidoreductase complex (Trumpower, 1990; 
Phillips and Trumpower, 1993). Cells carrying UBRl -expressing, high 
copy plasmids that also expressed a truncated QCR9 had a mild 
petite-like phenotype (slow growth on inefficiently fermentable  car- 
bon sources such as raffinose or galactose, data not shown). The 
-0.35-kb, Pcup, promoter-containing region of the plasmid pJDC22- 
2 (see below) was excised by Sat1 and  Sad,  and ligated into SalI/ 
SacI-cut pKM1307, yielding pKM1315, which expressed UBRl from 
the Pcupl promoter. (pJDC22-2 was constructed by a multistep pro- 
tocol (details available upon request) that included the insertion of a 
modified, PCup,  promoter-containing fragment from the plasmid 
YEp46 (Ecker et al., 1987) (a gift from D. Finley, Harvard Medical 
School, Boston, MA) into the BamHI-cut polylinker of YCplac22 
(Gietz and Sugino, 1988).) The plasmid pKM1315 was treated with 
SpeI and Klenow PoII, and self-ligated, producing a 4-base insertion/ 
frameshift  mutation at  the nucleotide position 510 in the UBRZ open 
reading frame (Bartel et al., 1990). The resulting plasmid, pKM1320, 
expressed a 170-residue N-terminal fragment of the 1,950-residue 
Ubrl protein  (the  mutation produced a  stop codon immediately after 
the nucleotide position 510). Neither pKM1315 nor pKM1320 inhib- 
ited cell growth under conditions that induced their UBR1-linked 
Pcupl promoter (0.1 mM CUSOI, see Fig. 4). 
Isolation of RNA and Northern Hybridization-A slight modifica- 
tion of the procedures described by Baker et al. (1992) was used. S. 
cereuisiae strains KMY633,634 and 635 (Table I) were  grown to A600 
of -1 in SR medium containing 0.1 mM CuSO4 and lacking uracil 
and tryptophan.  A 15-ml sample of each culture was centrifuged to 
pellet the cells, which were then washed with 1 ml  of water. Galactose 
was added to  the remainder of the cultures to a  final  concentration 
of  3%. Samples were withdrawn from the cultures 1,2,  and 3 h  after 
the addition of galactose. Washed cell pellets were resuspended in 
0.25  ml of ice-cold TEN buffer (0.5 M NaC1, 10 mM Na-EDTA, 0.2 M 
Tris-HC1, pH 7.5). An equal volume of glass beads and 0.25 ml of 
phenol-chloroform (l:l, equilibrated at  pH 8) were added, followed 
by vortexing at  maximum speed for 2 min, with intermittent cooling 
on ice (Silverman, 1987). The samples were centrifuged at 12,000 X 
g for 1 min, and  the aqueous phase was reextracted twice with phenol- 
chloroform, followed by the addition of 2 volumes of  95% ethanol and 
incubation at -20 "C to precipitate nucleic acids, which were re- 
covered by centrifugation at  12,000 x g for 5 min. The nucleic acid 
pellets were dissolved in  2 mM dithiothreitol  containing 500 units/ml 
of RNAsin (Promega) The concentration of RNA was determined by 
measuring A2w (these  preparations  contained negligible amounts of 
DNA, data  not shown). 
For  Northern hybridization, a slightly modified procedure of 
McMaster and Carmichael (1977) was used.  25  pg of total RNA  was 
treated with 1.5 M deionized glyoxal, 50% dimethyl sulfoxide, 10 mM 
sodium phosphate, pH 6.5, at 50 "C for 1 h, cooled, and electropho- 
resed at 4 V/cm, with recirculation of electrophoretic buffer, in an 
0.8% agarose gel containing 10 mM sodium phosphate, pH 6.5. The 
gel was incubated in 25 mM sodium phosphate, pH 6.5, for 15 min, 
and  the RNA was transferred by blotting in the same buffer to a 
Genescreen  membrane  (Du Pont).  The gel  was stained with ethidium 
bromide and photographed at  300  nm before and after the transfer to 
verify equimolarity of RNA sample loads and the uniformity of 
transfer. The membrane was heated at  85 "C for 3  h, placed in 7% 
SDS, 1% bovine serum albumin, 0.5 M sodium phosphate, pH 7.0, 
sealed in a plastic bag, and prehybridized for 30 min at 65  'C. 32P- 
Labeled DNA probes were prepared by the method of Feinberg and 
Vogelstein (1984), using 0.1 pg of gel-purified DNA fragments. The 
heat-denatured DNA probes were added to  the plastic bag and incu- 
bated with the membrane-immobilized RNA for -15 h at 65 "C. The 
membrane was then washed twice for 30 min at 65 T in 0.2% SDS, 
0.3 M NaC1, 30 mM sodium citrate, pH 7.0. 
The UBRZ-specific probe was a -5.3-kb SpeI-KpnI fragment of 
pSOB44 (Bartel et al., 1990) that is contained within the UBRl open 
reading frame. The UBCZ-specific probe was a -0.6-kb  EcoRI frag- 
ment of pDG309 (see above) that included the  entire 516-base pair 
open reading  frame of UBC2. The probes were labeled with 32P and 
mixed together before hybridization. After completion of the North- 
ern analysis, a  control hybridization was carried out with the same 
membrane (without removing the hybridized UBRl and UBC2 
probes), using a 32P-labeled ACT1 (yeast  actin gene) probe (a -2-kb 
BamHI-PstI  fragment of pTB392; a gift of J. Jones, McArdle Labo- 
ratory, University of Wisconsin, Madison, WI). Hybridization pat- 
terns were detected either by standard autoradiography with x-ray 
12048 N-recogninlUbc2  Interactions 
films or using a PhosphorImager (Molecular Dynamics, Sunnyvale, 
CA) (Johnston et al., 1990; Tobias et al., 1991) and quantified as 
described in the legend to Fig. 40. 
Coimmunoprecipitation Assay-Cells from 20-ml exponential yeast 
cultures ( A m  < 1) of the strain BBY68 (ubc2A ubrlA, Table I) 
transformed with various plasmids (see “Results”) were collected by 
centrifugation at 2,500 X g for 5 min, resuspended in 0.5 ml of SD 
medium lacking methionine, and labeled with 0.2  mCi of [%]Tran- 
slabel ( E N )  for 30  rnin at  30 “C. The labeled cells were pelleted by 
centrifugation, resuspended in 0.5 ml of DB buffer (50 mM NaCl, 1 
mM Na-EDTA, 50 mM Na-HEPES, pH 7.5) containing protease 
inhibitors leupeptin, pepstatin A, antipain,  chymostatin, and apro- 
tinin (each at 20 pg/ml, Sigma), and lysed by vortexing with glass 
beads (Bartel et al., 1990). The extracts were centrifuged at 12,000 x 
g for 10 min. Immunoprecipitation assays were carried out with the 
supernatants by adding ascitic fluid (1 p1/0.3 ml of a supernatant) 
containing the  anti-ha monoclonal antibody 12CA5 (Field et al., 1988) 
(Babco Inc., Richmond, CA) to  the single or mixed extracts described 
under “Results” and in the legend to Fig. 2.  All samples also contained 
a -10-fold excess of an identically prepared  yeast extract from un- 
transformed, unlabeled BBY68 (ubc2A ubrlA) cells. The samples 
were incubated on ice for 2 h; 20 pl of Protein A-Sepharose (Repligen, 
Cambridge, MA)  was then added, and  the suspensions were incubated, 
with end-over-end rotation, for 1 h at 4 “C, followed  by a 5-8 centrif- 
ugation in  a microcentrifuge. Pellets were washed four times with 0.8 
ml of DB buffer containing 5% glycerol, resuspended in electropho- 
retic sample buffer, heated at 100 “C for 3 min, and subjected to SDS- 
PAGE (13%), followed  by fluorography. ‘%-Labeled SDS-PAGE 
protein standards were from Amersham Corp. 
Interaction Cloning of Ubc2-binding Protein Domains-The S. 
cerevisiae UBC2 gene containing an EcoRI site immediately 5’ to  its 
start (ATG) codon (a gift from R. D. Gietz) was isolated as a 525- 
base pair EcoRI-SalI fragment and ligated into EcoRIISalI-cut 
pMA424 (Ma and  Ptashne, 1987), yielding the plasmid pKM1210-1, 
which expressed a fusion containing the DNA-binding domain of 
Gal4 upstream of the complete sequence of Ubc2. The S. cereuisiae 
strain GGY1::171 (Gill and  Ptashne, 1987) was transformed  (Schiestl 
and Gietz, 1989) with pKM12lO-1. His+ transformants were selected 
on DOBA-his plates (BIOlOl), yielding KMY528 (Table I). This 
strain was transformed with DNA pools from the three libraries 
pGAD1,2, and 3, in which yeast genomic  DNA fragments (produced 
by a partial Sau3A digestion) had been fused, in three different 
frames, to  an upstream fragment that encoded the activation domain 
of Gal4 (Chien et al., 1991; a gift from P. Bartel, SUNY, Stony Brook, 
NY). Transformants were selected on DOBA-his-leu plates (BIOlOl), 
and -1.5 X lo6 colonies were replica-plated onto the same medium 
containing the chromogenic 8-galactosidase substrate XGal (Chien 
et al., 1991). 
This screen yielded 14 blue transformants  that remained blue upon 
restreaking. The HZS3-based pKM1210-1 was evicted from these 
transformants by growing them  on  histidine-containing medium. The 
library-derived plasmids were isolated from the resulting His- trans- 
formants as described by Hoffman and Winston (1987) and  trans- 
formed into  the Escherichia coli strain DH5a  The amplified plasmids 
were purified from E. coli and transformed into KMY528 (Table I), 
confirming the results of the initial XGal screen. Nucleotide sequenc- 
ing, using the chain  termination method (Ausubel et al., 1989), of the 
yeast DNA inserts in the plasmids showed that all but one insert 
encoded Ga14. This insert was found to encode a -170-residue C- 
terminal fragment of the 1,950-residue Ubrl protein (plasmid 
pKM1312, the exact number of Ubrl residues encoded by the 
pKM1312 insert is not given because the corresponding sequencing 
gel was unreadable close to the sequencing primer site; data not 
shown). In a negative control, pKM1312 was transformed into  the 
GGY1::171 strain carrying pEE5, a plasmid that expressed a fusion 
of the DNA-binding domain of Gal4 to Snfl, a  protein presumably 
unrelated to Ubc2 (Yang et al., 1992). As expected, these  transform- 
ants yielded white colonies on XGal plates. 
RESULTS 
The Acidic C-terminal Region of Ubc2 Is Required for Deg- 
radation of N-end Rule Substrates-Degradation of proteins 
by the N-end rule pathway was assayed in vivo using deriva- 
tives of E. coli @-galactosidase (@gal) as model substrates.  In 
eukaryotes, Ub fusions such as Ub-X-@gal are precisely deu- 
biquitinated either in vivo or in cell-free extracts by Ub- 
specific processing proteases to yield X-@gal test proteins 
bearing the desired residue X at  the N-terminus (Bachmair 
et al., 1986; Gonda et al., 1989). In  contrast  to  the function of 
Ub in  protein degradation, the role of Ub in these engineered 
Ub fusions is to allow the in uiuo generation of otherwise 
identical proteins bearing different N-terminal residues. De- 
pending on  the identity of X, the X-@gal proteins  are  either 
long-lived or metabolically unstable, with destabilizing N- 
terminal residues conferring short half-lives on the corre- 
sponding X-@gals (Bachmair et al., 1986; Tobias et al,, 1991). 
This  N-terminal degradation signal (the N-degron) is mani- 
fested as  the N-end rule. 
Previous work (Dohmen et ai., 1991a) has shown that  the 
normally short-lived  N-end rule substrates such as Arg-@gal 
are long-lived in S. cereuisiae strains lacking the UBC2 gene. 
One feature of the 172-residue Ubc2 Ub-conjugating enzyme 
is its highly acidic 23-residue C-terminal region which con- 
tains 20 acidic residues (Asp or Glu) (Fig. lA, Reynolds et  al., 
1985). The acidic “tail” of Ubc2 is required for some but 
apparently  not for all of the Ubc2 functions. In particular, 
strains whose mutant Ubc2 protein lacks the acidic tail  are 
unable to sporulate  (as homozygous ubc2 diploids), but  they 
are nearly wild-type in  their ability to carry out DNA repair 
and induced mutagenesis, in marked contrast to congenic 
ubc2A strains  (Morrison et al., 1988). 
Given this earlier evidence, we asked whether tailless var- 
iants of  Ubc2 are active in  the N-end rule pathway. Otherwise 
identical plasmids expressing either the wild-type Ubc2 or  its 
C terminally  truncated derivatives (Fig. 1A) were transformed 
into a ubc2A yeast strain  that expressed either Arg-Bgal (Ub- 
B 
I Met-mal T 
Ut&-172 UW-(€4 ubc2.153 UbcZ-149 UDCZCBBA UWZA 
FIG. 1. UBC2 allelea and their activity in the  N-end  rule 
pathway. A, schematic representation of the 172-residue Ubc2, its 
C-terminally truncated derivatives (Ubc2-164, Ubc2-153, and Ubc2- 
149), and  the enzymatically inactive Ubc2-C88A, in which the active- 
site Cys-88 has been replaced by Ala (filled  portions of the rectangles 
denote the 23-residue polyacidic tail). See also main text. B, levels of 
pgal activity in the S. cereuisiae strain BBY67 (ubc2A) carrying 
plasmids pUb23M or pUb23R that expressed Ub-Met-@gal (black 
bars) or Ub-Arg-@gal (striped  bars) from the galactose-inducible 
GAL10 promoter  (Bachmair et al., 1986), and also either  a low-copy 
(CEN-based) plasmid YCplac33 (vector alone; denoted as ubc2A) or 
similar plasmids pR67 (Morrison et al., 1988), pR617, pR616, pR615, 
and pR647 expressing, respectively, Ubc2-172 (wt), Ubc2-164,  Ubc2- 
153,  Ubc2-149, and UbcZ-CS8A (see also “Experimental Procedures” 
and Table I). Values shown are the means of three duplicate meas- 
urements with three  independent  transformants. Standard deviations 
are indicated above the bars. 
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Arg-Bgal) or Met-@gal (Ub-Met-Bgal) (see the legend to Fig. 
1). Arg is  a type 1 primary destabilizing residue in the N-end 
rule, whereas Met is a stabilizing residue (see Introduction). 
Metabolic stabilities of Arg-(?gal and Met-(?gal were compared 
by determining their  intracellular  concentrations (Fig. 1B). 
Previous work (Bartel  et al., 1990; Balzi et al., 1990; Baker 
and Varshavsky, 1991; Dohmen et al., 1991a) has shown that 
the steady state level of an X-(?gal protein  in yeast cells is a 
sensitive indicator of i ts  metabolic stability; compare, for 
example, the levels of Met-@gal (till > 20 h) and Arg-(?gal 
( t 1 / 2  of -3 min)  (Bachmair et al., 1986) expressed from iden- 
tical vectors in cells that also expressed the wild-type UBC2 
gene (Fig. lB, Ubc2-172). However, in the congenic ubc2A 
cells, the level of  Arg-Bgal was much higher, close to  that of 
Met-Bgal (Fig. lB, &PA), in agreement with earlier findings 
(Dohmen et al., 1991a). 
As can be seen from the  data in Fig. lB,  the shortening of 
the 23-residve acidic tail of Ubc2  by 8 residues (yielding Ubc2- 
164) did not impair the ability of Ubc2 to support the degra- 
dation of Arg-(?gal, whereas the Ubc2-153 derivative which 
lacked all but  4 residues of the acidic tail was severely im- 
paired in  this function (Fig. lB, Ubc2-164 versus Ubc2-153). 
The residual activity of Ubc2-153 in the N-end rule pathway 
could  be eliminated by deleting the 4 remaining residues of 
the acidic tail (Fig. lB, Ubc2-149 versus  Ubc2-153). 
The level of the normally short-lived Arg-(?gal in cells 
expressing the entirely  tailless Ubc2-149 was indistinguisha- 
ble from the level of the normally long-lived Met-(?gal (Fig. 
lB, Ubc2-149). In  contrast, the level of  Arg-Bgal was signifi- 
cantly (and reproducibly) lower than that of Met-(?gal in 
ubc2A cells (Fig. lB, Ubc2A). Cells lacking Ubc2 are known 
to contain elevated levels of other Ub-conjugating (E2)  en- 
zymes, in particular Ubc4 (data  not shown). This apparently 
"reciprocal" cross-regulation among E2 enzymes suggests the 
following explanation for a paradoxically higher residual ac- 
tivity of the N-end rule pathway in the total absence of Ubc2 
than in the presence of the tailless Ubc2. First, it  is assumed 
that  at least some of the E2 enzymes other  than Ubc2 have a 
weak but significant affinity for the UBRl-encoded N-recog- 
nin. Second, it is assumed that expression of either the wild- 
type Ubc2 or  its tailless derivative such as Ubc2-149 down- 
regulates the expression of the postulated "cross-comple- 
menting" E2 enzymes. This model  could account for the above 
results (Fig. lB, Ubc2-149 versus UbcPA), because a (hypo- 
thetical) cross-complementing E2 enzyme would be induced 
in  a ubc2A strain  but  not  in  a ubc2-149 strain. Examples of 
at least  partial  functional complementation between different 
E2 enzymes in yeast have been reported previously. For 
instance, overexpression of the yeast UBC5 gene partially 
complements proteolytic defects of the h 4 A  mutant (Seufert 
and  Jentsch, 1990). 
The Acidic C-terminal Region of Ubc2 Is Required for High 
Affinity Binding of Ubc2  to N-recognin-Earlier coimmuno- 
precipitation experiments have shown that the UBRl-en- 
coded N-recognin is physically associated with Ubc2 (Dohmen 
et al., 1991a). We asked whether  a  Ubrl.Ubc2 complex that 
is stable enough to be detectable in  a coimmunoprecipitation 
assay requires the presence of the acidic C-terminal region in 
Ubc2. A modified Ubrl protein used in  these  experiments  had 
its C-terminus extended with a 9-residue sequence derived 
from hemagglutinin (ha) of influenza virus and  containing an 
epitope (the ha tag) recognizable by the monoclonal antibody 
12CA5 (Bartel et al., 1990; Dohmen et al., 1991a). The epitope- 
tagged Ubrl  (Ubrl-ha) was functionally active, in that  the 
UBRl -ha gene and  the unmodified UBRl gene  were indistin- 
guishable in their ability to complement the ubrlA  mutant 
(Bartel et al., 1990). When overexpressed from the ADHl 
promoter on a high copy plasmid, the -226-kDa Ubrl-ha 
protein could be immunoprecipitated from ["S]methionine- 
labeled cell extracts with the anti-ha monoclonal antibody 
(Fig. 2A, lane b; compare with lone a )  (dots in Fig. 2A mark 
the two Ubrl-unrelated  yeast  proteins  that cross-reacted with 
the anti-ha monoclonal antibody; these proteins were also 
present in cells lacking the UBRl and  URRl-ha genes, and 
in addition  almost comigrated with Ubrl-ha upon SDS- 
PAGE; see also Bartel  et al. (1990) and Dohmen et af. (1991a)). 
Extracts were prepared from ["S]methionine-labeled ubrlA 
ubc2A cells transformed with either  a control plasmid (vector 
alone), a plasmid expressing Ubrl-ha,  or  a plasmid expressing 
the wild-type Ubc2 or  its mutated derivatives. The control 
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FIG. 2. The plyacidic tail of Ubc2 in required far high 
affinity binding of Ubc2 to N-r-in. Extractn were prepared 
from  exponentially growing, ["Sjmethionine-labeled BRYGR ( u b r l A  
h 2 A )  cells that  had been transformed with one of the following 
high  copy (2p-hased)  plasmids:  YEplacl95ADH  (vector  alone): 
pSOB44  (expressing  the ha epitope-tagged Uhrl-ha from the A D H l  
promoter (Rartel et al., 1990));  pAI)HURC2,  pJD647, pJD617, 
pJD616.  and  pJD615  (the  YEplacl95ADH-had  plasmids  express- 
in& respectively, Ubc2-172 (wt), UhcZ-CMA, Ubc2-164, Uhc2-1.53 
and Ubc2-149 from the ADHI promoter) (see "Experimental Pme- 
dures").  Extracts  from %labeled  cells  (-1 X 10' acid-insoluble 
counts/minute/extract) carrying either the control plasmid (vector 
alone, labeled - atop the lanes a, c, e, R, i,  and k) or the plasmid 
expressing  Ubrl-ha  (labeled + atop  the lanes 6. d, f. h, j ,  and I )  were 
mixed either with a labeled extract from "S-labeled control cells 
(carrying  vector  alone; lanes a and 6) or with  extracts  from ".%-labeled 
congenic cells carrying  plasmids that expressed Uhc2 and its deriva- 
tives (-0.75 X lo' acid-insoluble  counts/minute/extract): Ubc2-172 
(wild type) (lanes c and d ) ;  Ubc2-CfMA (kanes e and f); Uhc2-164 
(lanesg and h);  Ubc2-153 (lanes i and j ) ;  and Ubc2-149 (lanes k and 
I ) .  After  removing a portion of each  sample for the  analysis of total 
protein, the mixed extracts  were  subjected to immunoprecipitation 
with a monoclonal antibody to the ha epitope, followed by SDS- 
PAGE  (13%)  and  fluorography (see "Experimental Procedures"). A, 
A 3-h fluorographic exposure of an upper portion of the gel that 
shows the immunoprecipitated -226-kDa Ubrl-ha (lanes 6, d,  f. h. j ,  
and 1 ) .  DoLv mark  two  unrelated  yeast  proteins  (present  in all lanes) 
that  cross-react  with  the  anti-ha  antibody  (Dohmen t 01,. 1991a). R.  
a 48-h fluorographic  exposure of a lower portion of the  same gel ae in 
A. Positions of the  coimmunoprecipitated 172-residue (20  kDa) Uhc2- 
172  (wild-type), Ubc2-CfMA, and  the 164-residue Uhc2-164 are indi- 
cated. Also denoted  is  the  position of a  -22-kDa protein ( ~ 2 2 )  that 
coimmunoprecipitated  with  Uhrl-ha  irrespective of the presence or 
absence of Uhc2 in the mixed extracts  (this  panel  and  data not shown; 
see also  main  text). C, the  same  molecular  mass  range  as in R,  in an 
identically run gel that  was loaded with mmples (1% of total "S 
counts/minute)  from  each of the mixed extracts before immunopre- 
cipitation,  confirming  the  approximate  equimolarity of Uhc2 variante 
in  the  initial  extracts.  Positions  and  lengths of Uhc2-172 and iLq C 
terminally truncated derivatives are indicated by numbers on the 
right. 
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extract (lacking both Ubrl-ha  and Ubc2 or its derivatives) 
was processed for immunoprecipitation with the  anti-ha 
monoclonal antibody either alone (Fig. 2, A and B, lane a )  or 
after having been mixed either with the  extract containing 
Ubrl-ha (Fig. 2, A and B, lune b )  or with the  extract containing 
Ubc2 (or its derivatives) (Fig. 2, A and  B, lanes c, e, g, i, and 
k). Each of the Ubc2-containing extracts was also mixed with 
the extract  containing Ubrl-ha,  and  the mixed extracts were 
incubated with the  anti-ha monoclonal antibody (Fig. 2, A 
and B, lunes d, f, h, j ,  and I ) .  The antibody precipitated the 
Ubrl-ha protein from all samples that contained Ubrl-ha 
(Fig. 2A, lanes b, d, f ,  h, j ,  and 1 ) .  Crucially, the antibody did 
not precipitate proteins the size of Ubc2 (19.7 kDa) or its 
derivatives from samples containing Ubc2 but lacking Ubrl- 
ha (Fig. 2, A and B, lanes c, e, g, i, and k). However, immu- 
noprecipitation from the sample containing both Ubrl-ha  and 
the wild-type Ubc2 protein yielded not only Ubrl-ha  but also 
a  protein the size of Ubc2  (Fig. 2, A and B, lanes d; compare 
with lane c), confirming the earlier finding that  the wild-type 
Ubc2 is physically associated with Ubrl (Dohmen et al., 
1991a). 
Similar assays with Ubrl-ha and the C-terminally trun- 
cated Ubc2 derivative Ubc2-164,  which lacks a  portion of the 
acidic tail  but is fully active in  the N-end rule pathway (Fig. 
lB, Ubc2-164), also resulted in the coimmunoprecipitation of 
Ubc2-164 and  Ubrl-ha (Fig. 2, A and  B, lane h; compare with 
lane g). The same experiment was carried out with more 
extensively truncated Ubc2 derivatives, Ubc2-153 and Ubc2- 
149. The former lacks all  but  4 residues of the acidic tail  and 
is nearly inactive in the N-end rule pathway, while  Ubc2-149 
lacks the entire acidic tail and has no detectable activity in 
the pathway (Fig. lB, Ubc2-153 and Ubc2-149). Neither 
Ubc2-153 nor Ubc2-149 were coimmunoprecipitated with 
Ubrl-ha, in contrast to either  the wild-type Ubc2 or Ubc2- 
164 (Fig. 2, A and B, lanes j and I; compare with, for instance, 
lane h ) .  
We conclude that a  portion of the 23-residue acidic tail of 
UbcP that is longer than 4 residues but shorter than 16 
residues is sufficient for both  a high affinity (coimmunnopre- 
cipitation assay-detectable) binding of Ubc2 to  Ubrl  and for 
the function of Ubc2 in  the N-end rule pathway. Regions of 
the Ubc2 enzyme other than the acidic tail may also be 
involved in functionally relevant  interactions with N-recog- 
nin,  or in other  N-end  rule-related functions, because neither 
the Ubc3 (Silver et al., 1992; Kolman et al., 1992) nor the 
Ubc4 Ub-conjugating enzyme that have been modified  by the 
addition of the Ubc2-specific acidic tail could complement the 
N-end rule defect of a ubc2A   train.^ 
N-recognin Is Bound to a -22-kDa Protein-The anti-ha 
antibody precipitated not only the -226-kDa Ubrl-ha  and 
the -20-kDa UbcP (see above), but also a protein with an 
apparent molecular mass of -22 kDa, termed p22 (Fig. 2B, 
lanes b, d, f, h, j ,  and 1 ) .  The presence of p22 in an  anti-ha 
immunoprecipitate required the presence of Ubrl-ha  in  the 
initial  extract  but did not depend on the presence of Ubc2 
(data  not shown and Fig. 2B, lanes b and d; compare with 
lanes a and c). Thus,  the  apparent association of p22 with N- 
recognin does not require an  intact N-recognin . Ubc2 com- 
plex. The possibility that p22 is a C-terminal proteolytic 
fragment of Ubrl-ha  that bears the  ha  tag  and is therefore 
immunoprecipitable with the  anti-ha antibody was tested by 
constructing a Ubrl variant that bore two consecutive C- 
R. J. Dohmen, K. Madura, and A. Varshavsky, unpublished data 
(a plasmid expressing a derivative of Ubc3 that bore the Ubc2-specific 
acidic tail was kindly provided by  M. Ellison, University of Alberta, 
Edmonton,  Canada). 
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control Ubc2-172 Ubc2-149 UbC2-C88A 
FIG. 3. The inactive Ubc2-CSSA derivative of the Ubc2 Ub- 
conjugating enzyme is an inhibitor of the N-end rule pathway. 
Levels of @gal activity in the S. cerevisiae stain YPH500 (UBRl 
UBCZ) carrying the LEU2-based, high copy plasmid pRL2 that 
expressed Ub-Arg-@gal (Bartel et al., 1990, and  data  not shown), and 
also either the plasmid YEplacl95ADH (vector alone; control) or its 
derivatives (pADHUBC2, pJD615, and pJD647) that expressed, re- 
spectively, Ubc2-172 (wild-type), Ubc2-149, and Ubc2-C88A from 
the ADHl promoter (see also “Experimental Procedures” and Table 
I). Values shown are the means of four measurements carried out 
with four independent  transformants. Standard deviations are shown 
above the burs. 
terminal ha tags: Immunoprecipitation from an extract con- 
taining Ubrl-ha-ha should have resulted in a detectable (-1.5 
kDa) increase in the size of the p22 protein if it were a C- 
terminal  (ha-bearing)  fragment of Ubrl-ha-ha. No such  in- 
crease was observed (data  not shown), suggesting that p22 is 
a  distinct  Ubrl-associated  protein. 
A Dominant  Negative Allele of UBC2-Cys-88, the only Cys 
residue in the Ubc2 Ub-conjugating enzyme, has been shown 
to be the site of Ub thioester  formation; replacement of Cys- 
88 in Ubc2 with either Ala or Val eliminates the Ub-conju- 
gating activity of Ubc2 and renders it biologically inactive 
(Sung et al., 1990). As could be expected from these earlier 
findings, the Ubc2-C88A  (Cys-Ala) derivative was found to 
be inactive in  the N-end rule pathway (Fig. lB, Ubc2-C88A). 
However, in  contrast  to  the effect of overexpressing the  tail- 
less Ubc2-149 (which does not  bind  to N-recognin and is also 
inactive in the N-end rule pathway; see above), overexpression 
of Ubc2-C88A in wild-type (UBC2) cells resulted in strong 
inhibition of the N-end rule pathway (Fig. 3). No such inhi- 
bition was observed upon overexpression of the wild-type 
UBC2 (Fig. 3). A likely reason for the difference between the 
effects of overexpressing Ubc2-149 and Ubc2-C88A is indi- 
cated by the finding that Ubc2-C88A, unlike Ubc2-149, re- 
tains  the ability of the wild-type Ubc2 to form a high affinity 
complex with the UBRl-encoded N-recognin (Fig. 2, A and 
B, lune f ;  compare with lane 1 ) .  
R. J. Dohmen, N. Schnell, and A. Varshavsky, unpublished data. 
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Thus, ubcZ-C88A is  a  dominant negative allele of the UBC2 
gene,  whose interference with the N-end rule pathway is likely 
to result from competition between the wild-type Ubc2 and 
Ubc2-C88A for binding to N-recognin. Although the Ubc2 
regions in  contact with N-recognin are unlikely to be confined 
to  the acidic tail of Ubc2 (see above), the overall affinity of 
“non-tail” Ubc2 regions for N-recognin is at most low:  Ubc2- 
149 is not coimmunoprecipitated with N-recognin (Fig. 2), 
and  the inhibition of the  N-end rule pathway by  Ubc2-149 is 
much weaker than the inhibition by Ubc2-C88A (Fig. 3, 
compare Ubc2-149 with UbcZ-C88A). 
Ubc2-C88A,  which lacks the thioester-forming Cys residue 
of the wild-type Ubc2, cannot accept Ub from the Ub-acti- 
vating (El) enzyme (Sung  et al., 1990). The apparently un- 
diminished affinity of Ubc2-C88A for N-recognin (see above) 
suggests that interactions between N-recognin and Ubc2 do 
not involve the thioester-bound Ub moiety of the wild-type 
Ubc2 (at the in vivo concentrations of U b ,  Ubc2, and the 
UBAl -encoded El  enzyme, the bulk of Ubc2 is likely to bear 
the thioester-bound Ub moiety (Pickart, 1988)). 
Ubc2-interacting Domain of N-recognin-To identify the 
domains of N-recognin that  interact with the Ubc2 Ub-con- 
jugating enzyme in vivo,  we have used the “two-hybrid” inter- 
action cloning technique of Fields and Song (1989). In  this 
method, the expression of the E. coli lac2 reporter gene from 
the GAIA-dependent P G A L l  promoter in S. cerevisiae is de- 
signed to require the reconstitution of Gal4 activity from two 
unlinked but interacting protein domains. Specifically, the 
DNA-binding domain of the Gal4 protein  is expressed in yeast 
as a fusion whose C-terminal portion is a polypeptide of 
interest.  These cells are  transformed with a library in which 
quasi-randomly generated DNA fragments (from yeast or 
other species) are fused to a  fragment that encodes the Gal4 
transcription  activation domain. Transformants expressing a 
polypeptide from the library that has  a significant affinity to 
the polypeptide of interest can be identified as those that 
induce their resident PGALl-hZ reporter gene because the 
DNA-binding and activation domains of Gal4 are brought 
into  spatial proximity through the interaction of polypeptides 
fused to each domain (Fields and Song, 1989; Chien et al., 
1991; Chevray and  Nathans, 1992; Yang et al., 1992). 
The S. cerevisiae strain GGY1::171, which lacks both GAL4 
and  GAD0 genes and  contains an integrated PGALl-lacZ re- 
porter construct (Chien et al., 1991), was transformed with 
the plasmid pKM1210-1 which expressed the Gal4 DNA- 
binding domain fused to  the  N-terminus of the full-length 
Ubc2. The resulting strain, KMY528,  was transformed with 
PGAD-based DNA libraries that expressed the DNA-binding 
domain of Gal4 fused (in all three  frames) to partial Sau3A 
fragments of the yeast genomic DNA (Chien  et al., 1991; see 
“Experimental Procedures”). 14 lacZ-expressing transform- 
ants were identified among -1.5 X lo6 colonies screened. 
While most of the pGAD plasmids from the positive trans- 
formants  carried the  intact GAL4 gene (the pGAD libraries 
were derived from a GAIA yeast strain), one transformant 
was found to express a -170-residue C-terminal  fragment of 
N-recognin (Ubrl) fused to  the Gal4 activation domain. The 
corresponding pGAD-based plasmid, termed pKM131.2, re- 
producibly activated the expression of the PGALl-hZ reporter 
gene upon retransformation of the KMY528 strain (GGY::171 
carrying pKM1210-1). In a control experiment (data not 
shown), the same plasmid did not  activate the expression of 
P G A L I - ~ ~  in GGY1::171 carrying the plasmid pEE5, which 
expressed the DNA-binding domain of Gal4 fused to a region 
of a presumably unrelated  protein Snfl (Yang et al., 1992). 
We conclude that a C-terminal region of N-recognin that 
encompasses approximately 10% of this 1,950-residue protein 
contains  a  Ubc2-interacting domain. 
Regulatory Interactions between UBCZ and UBRI-In the 
course of earlier  experiments (Dohmen et al., 1991a), it was 
noticed that  Ubrl  and Ubc2 could not be overproduced si- 
multaneously within the same yeast cells. It was subsequently 
found that  the levels of UBRl mRNA (expressed from the 
strong P A D H I  promoter on a high copy plasmid) were  high in 
the absence of UBCZ expression (in ubc2A cells) but much 
lower  if cells carried a high copy plasmid overexpressing UBC2 
from the PADHI promoter. In addition, the copy number of a 
UBRl -expressing plasmid was decreased in  the presence of a 
plasmid expressing UBCZ but not in the presence of an 
otherwise identical plasmid lacking UBC2, suggesting that 
simultaneous overexpression of UBRl and UBC2 is cyto- 
toxic.’ 
To verify and analyze this effect, we constructed a high 
copy plasmid that expressed UBRl from the copper-inducible 
Pcupl promoter, as well as  a low  copy (CEN-based) plasmid 
that expressed UBCZ from the galactose-inducible PGAL~ pro- 
moter. Both plasmids were transformed  into the ubrl A ubc2A 
strain KMY618, yielding the  strain KMY633 (Table I), which 
was propagated in the raffinose-containing SR medium in the 
absence of added copper ions, conditions which do not induce 
the P G A L l  and Pcupl promoters. (Induction of the P G A L ~  pro- 
moter by galactose in cells that have been growing in the 
presence of raffinose is much faster than in cells that have 
been growing in the presence of dextrose (Griggs and  John- 
ston, 1991; Johnston, 1987).) 
The  strain KMY633  was  grown in SR medium containing 
0.1 mM CuS04 (conditions that induce PCUpl-UBRl but  not 
PGALI-UBCZ) to a midexponential phase (Asoo 5 l ) ,  followed 
by the addition of galactose to a final concentration of 3% 
(conditions that induce PGALl-UBCS as well). RNA was  iso- 
lated from cells either immediately before or (at hourly inter- 
vals) after the addition of galactose, followed by Northern 
analysis with UBRl and UBCZ hybridization probes (Fig. 4). 
While no expression of  UBC2 was detectable in SR medium, 
UBC2 mRNA accumulated to a high level within 1 h  after the 
addition of galactose (Fig. 4A, UBC2; compare lanes a  and b). 
Conversely, the level of UBRl mRNA was high in SR medium 
but decreased by approximately 2.5-fold within 1 h  after the 
addition of galactose, and remained low afterward (Fig. 4A, 
UBRI; compare lanes a  and b-d; see also Fig. 40).  The rapid 
decrease of UBRl mRNA level upon induction of UBC2 is 
likely to be caused by metabolic destabilization of UBRl 
mRNA, inasmuch as  both UBCZ and UBRl were expressed 
from heterologous promoters that are active in a copper- 
supplemented, galactose-containing medium. (Similar results 
were obtained when UBRl was expressed from the P A D H l  
promoter or from its natural (PUBR1) promoter (data not 
shown).) Moreover, since the doubling time of the KMY633 
cells in  this medium is approximately 3  h at 30 “C  (data  not 
shown), the rapidity of the observed decrease in the level of 
UBRl mRNA (Fig. 4, A and D )  is unlikely to result from 
dilution of this mRNA due to cellular growth. A UBCZ- 
induced destabilization of UBRl mRNA remains to be verified 
directly. 
The inhibitory effect of UBC2 expression on the level of 
UBRl mRNA was found to require the region that encodes 
the acidic C-terminal tail of Ubc2 (Fig. 1A): no significant 
decrease in the level of UBRl mRNA was observed upon 
induction of  ubc2-148 which encoded a tailless Ubc2 (Fig. 4, 
B and  D).  This result also confirmed that  the transfer of cells 
K. Madura, B. Bartel, R. J. Dohmen, and A. Varshavsky, unpub- 
lished data. 

























S. cerevkiae  strains 
Relevant markers 
MATa u r d  leu2 
MATa u r d  trpl leu2 
MATa u r d  ubc2A::LEU2 
MATa ubc2A::LEU2 urbl A 
MATa u r d  trpl ubcPA::LEU2 
MATa ubc2A::LEU2 + pUB23M 
MATa ubc2A::LEU2 + pUB23R 
ga14A  gaBOA u r d  his3 leu2 pGAL1::lacZ 
ubc2A::LEU2 + pUB23M + pR67 
ubcZA::LEU2 + pUB23M + pR615 
ubc2A:LEU2 + pUB23M + pR616 
ubc2A::LEUZ + pUB23M + pR617 
ubc2A::LEU2 + pUB23M + pR647 
ubc2A::LEU2 + pUB23R + pR67 
ubc2A::LEU2 + pUB23R + pR615 
ubc2A::LEU2 + pUB23R + pR616 
ubc2A::LEUZ + pUB23R + pR617 
ubc2A::LEU2 + pUB23R + pR647 
ga14AgaBOA + pKMI2lO-1 
ubcZA::LEU2 + pKM1167 + pKM1315 
ubc2A::LEU2 + pKM1166 + pKM1315 
ubc2A:LEUZ + pKMll67 + pKM1320 
Source/comment 
Sikorski and Hieter (1989) 
This work 
Derivative of YPH500, Dohmen et al. (1991) 
Dohmen et al. (1991) 
Derivative of JD47-13C, this work 
Derivative of BBY67,  this work 
Derivative of BBY67,  this work 
Fields and Song  (1989) 
Derivative of KMY306, this work 
Derivative of KMY306, this work 
Derivative of KMY306, this work 
Derivative of KMY306, this work 
Derivative of KMY306, this work 
Derivative of KMY307, this work 
Derivative of KMY307, this work 
Derivative of KMY307, this work 
Derivative of KMY307, this work 
Derivative of KMY307, this work 
Derivative of GGYl::171 
Derivative of KMY618, this work 
Derivative of KMY618, this work 
Derivative of KMY618. this work 
to galactose-containing medium did not, by itself, cause the 
observed decrease in UBRl mRNA. To determine whether 
the UBRl-suppressing effect of Ubc2 also required a func- 
tional Ubrl protein, we asked whether the induction of  UBC2 
decreased the level of an mRNA produced from an insertion/ 
frameshift ubrl allele that encoded a 170-residue N-terminal 
region of the 1,950-residue Ubrl protein. No significant effect 
of UBCZ on this  ubrl allele was observed (Fig. 4, C and D ) ,  
strongly suggesting that a functionally active Ubrl protein is 
required for down-regulation of UBRl mRNA by  UBC2. 
A likely explanation of these findings (Fig. 4) is that  the 
N-recognin . Ubc2  complex participates  in the regulation of 
the UBRl-encoded N-recognin. For  reasons considered above 
this regulation appears to involve an enhanced degradation 
of UBRl mRNA upon an increase in UBC2 expression. 
DISCUSSION 
Our previous work has shown that  the yeast N-recognin is 
physically associated with Ubc2, one of at least 10 Ub-conju- 
gating enzymes in S. cereuisiae and an essential component 
of the yeast N-end rule pathway (Dohmen et al., 1991a). 
Further analysis resulted in  the following main findings. 
(i) Both physical stability and functional activity of the  N- 
recognin . Ubc2  complex require the presence of a 23-residue 
C-terminal region in Ubc2 that contains 20 acidic residues 
(Asp or Glu). 
(ii) A Ubc2-interacting domain of the UBRl-encoded N- 
recognin is located within the 170-residue C-terminal region 
of the 1,950-residue N-recognin. Whether this is the only 
Ubc2-interacting region of N-recognin and whether  this re- 
gion interacts with the C-terminal acidic region of Ubc2 
remains to be determined. 
(iii) The ubc2-CB8A gene, in which the codon encoding the 
active-site Cys of Ubc2 has been replaced by an Ala codon, 
acts  as  a  dominant negative allele of  UBC2, most likely as  a 
result of competition between the wild-type Ubc2 and its 
enzymatically inactive variant for binding to N-recognin. 
(iv) Expression of  UBC2 decreases the level of UBRl 
mRNA which encodes N-recognin. This effect requires the 
intact N-recognin-Ubc2 complex and  is likely to result from 
enhanced degradation of UBRl mRNA upon an increase in 
UBC2 expression. 
Targeting Complex of the  N-end Rule Pathway-The known 
components of the S. cereuisiae N-end rule pathway that 
mediate steps prior to or distinguishable from the actual 
proteolysis of a  substrate  are  N-terminal amidase (Nt-ami- 
dase), encoded by the NTAl gene: Arg-tRNA-protein trans- 
ferase, encoded by the ATE1 gene (Balzi et al., 1990), N- 
recognin, encoded by the UBRl gene (Bartel et ul., 1990), the 
Ub-conjugating (E2) enzyme, encoded by the UBC2 gene 
(Reynolds et al., 1985; Jentsch et al., 1987; Dohmen et al., 
1991a), and  the Ub-activating (El) enzyme, encoded by the 
UBAl gene (McGrath et al., 1991). In addition to direct 
(immunoprecipitation-based) evidence for the physical asso- 
ciation between N-recognin and Ubc2 (see “Results”),  there 
is also circumstantial (overexpression-based) evidence for the 
existence of a ternary complex between N-recognin, Arg- 
tRNA-protein  transferase, and Nt-amidase‘ (these  latter com- 
ponents of the pathway modify N-termini of certain N-end 
rule substrates prior to their binding by N-recognin; see 
Introduction). 
Proteins that participate in a complex metabolic transfor- 
mation are often physically associated. The examples of a 
multienzyme assembly range from pyruvate dehydrogenase 
(synthesis of acetyl-coA) to replisome (DNA replication), 
spliceosome (RNA splicing), ribosome (protein synthesis), 
and proteasome complexes (protein degradation). Mechanis- 
tic advantages of such assemblies stem from their increased 
fidelity due to often present editing capabilities, and also from 
the properties of processivity and channeling that are  central 
to  the functioning of multienzyme machines. For example, 
the association between N-recognin and  the Ubc2 Ub-conju- 
gating enzyme not only endows the  latter with the ability to 
recognize a  substrate  that bears a destabilizing N-terminal 
residue but may also contribute to processivity of the Ubc2- 
mediated synthesis of a  substrate-linked  multi-Ub  chain. 
The targeting complex of the S. cereuisiae N-end rule path- 
way is likely to contain at least five components, Ntal,  Atel, 
Ubrl,  and Ubc2 (whose subunit molecular masses are, respec- 
tively, 52, 58, 225, and 20 kDa),  and also the  at least tran- 
siently associated 114-kDa Ubal (El) enzyme, which must be 
bound to Ubc2 during the E1+E2 transfer of an activated 
Ub moiety. That  this list is incomplete is suggested by the 
R. Baker and A. Varshavsky, manuscript in preparation. 
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FIG. 4. UBCB-mediated inhibition of UBR1. Northern analy- 
sis of electrophoretically fractionated total RNA from the S. cereuisiue 
strain KMY618 (ubrZA ubc2A, Table I) transformed with a plasmid 
that expressed wild-type UBC2 (or its derivative ubc2-148) from the 
galactose-inducible P G ~ L ~  promoter, and also with a plasmid that 
expressed wild-type UBRl (or  an insertion/frameshift allele of 
UBRl)  from the copper-inducible Pcupl promoter. Numbers at  the 
top indicate time  after the addition of galactose to cells growing in 
SR medium. The blots were hybridized simultaneously to UBRZ- and 
UBC2-specific probes labeled with 32P (see “Experimental Proce- 
dures’’). Because of different signal intensities from the -0.8-kb 
UBC2 mRNA and  the -7-kh UBRl mRNA, the images shown were 
produced by autoradiographic exposures of different durations. A,  
RNA  was isolated from exponentially growing cells ( A m  s 1) carrying 
plasmids that expressed wild-type UBRZ from the Pcupl promoter 
and wild-type UBC2 from the P G A L ~  promoter (strain KM633, Table 
I) immediately before and 1, 2, or 3 h  after the addition of galactose 
to cells growing in SR medium. Note the induction of the UBC2 
mRNA in the presence of galactose, and  the concomitant decrease in 
the level of the UBRl mRNA. B, same as in A but with RNA from 
cells that expressed ubc2-148 instead of the wild-type UBC2 (strain 
KMY634, Table I). An underloaded RNA sample was the reason for 
apparently lower  levels of both the UBRI and UBC2 mRNAs at  the 
2-h point (verified by ethidium staining of the gel and by hybridization 
with a  control ACTl probe; see D). C, same as in A but with RNA 
from cells that expressed an insertion/frameshift ubrl allele (encod- 
ing a short N-terminal fragment of Ubrl) instead of the wild-type 
UBRl (strain KMY635, Table I). D, the RNA blots in A-C were 
rehybridized with ACTI, the yeast actin gene (see “Experimental 
Procedures”). Hybridization signals from the UBRZ, UBC2, and 
ACT2 probes were recorded and quantified using PhosphorImager 
(Molecular Dynamics). The signals from the UBRl probe were nor- 
malized to those derived from the ACTl probe in each lane. Plotted 
are  the normalized UBRZ signals, with the signals a t  zero time  point 
denoted as “100%”. Filled squares, UBRlIUBC2; open squares, 
UBRZ/ubc2-149; crosses, ubrl frameshift allele/UBC2. 
finding of a -22-kDa protein  (distinct from the 20-kDa Ubc2) 
in association with N-recognin (see “Results”) and by the 
earlier data indicating that a partially purified Arg-tRNA- 
protein  transferase from rabbit reticulocytes is a -360-kDa 
complex of several subunits of Arg-tRNA-protein transferase 
associated with several subunits of Arg-tRNA synthetase 
(Ciechanover et al., 1988). If the yeast Arg-tRNA-protein 
transferase (encoded by A T E l )  is organized similarly to  its 
mammalian counterpart, the mass of the entire targeting 
complex in S. cereuisiae could be about 1,500 kDa. In uiuo, 
this complex should be bound to  the  rest of proteasome at  
least some of the time. The complete proteolytic  machine that 
implements the N-end rule is thus a  strikingly diverse assem- 
bly of enzymes and binding  factors whose combined size is 
comparable to  those of ribosomal subunits. 
Evolution of the Targeting Complex-Homologs of the S. 
cereuisiae Ubc2 enzyme are  present  in all  eukaryotes  exam- 
ined, from yeasts to mammals. However, while a slightly 
shorter counterpart of the acidic C-terminal tail of the S. 
cereuisiae Ubc2 is also present in Ubc2 from the related 
budding yeast Kluyueromyces l ~ c t i s , ~  this region is absent from 
the otherwise close homologs of Ubc2 such as  the Rhp6 Ub- 
conjugating enzyme of the fission yeast Schizosacchuromyces 
pombe (Reynolds et  al., 1990), and from the Drosophila, rabbit, 
and  human homologs of UbcP as well (Koken et al., 1991a; 
Wing et  al., 1992; Schneider et  al., 1990; Koken et al., 1991b). 
In S. cereuisiae, the tailless derivative of Ubc2 is inactive 
in  sporulation and in the N-end rule pathway but is able to 
support  other Ubc2 functions  such as DNA repair and induced 
mutagenesis at  nearly wild-type levels (see “Results” and 
Morrison et  al., 1988). The sporulation defect in cells contain- 
ing exclusively the tailless UbcP is unrelated to  their lack of 
the N-recognin-Ubc2 complex because S. cereuisiae is capable 
of sporulation  in the absence of N-recognin and hence in the 
absence of the N-end rule pathway (Bartel et al., 1990). Thus, 
it is likely that  the acidic tail of Ubc2 is also required for an 
interaction  with an unknown Ubc2-specific recognin whose 
function is essential for sporulation  in S. cereuisiae. 
The  naturally tailless Ubc2 homolog Rhp6 of S. pombe was 
shown to complement the known phenotypes of ubc2A S. 
cereuisiae except for its defect in  sporulation  (complementa- 
tion of the N-end rule defect has  not been tested) (Reynolds 
et al., 1990). Conversely, the tailless derivative of the S. 
cereuisiae Ubc2 enzyme could complement all of the tested 
defects of an rhp6A S. pombe mutant, including its sporulation 
defect (Reynolds et  al., 1990). Either  the wild-type or tailless 
Ubc2 of S. cereuisiae could function as  an N-end rule-media- 
ting enzyme in an  extract from rabbit reticulocytes (Sung et 
al., 1992). 
The tailless Ubc2 might have preceded its acidic tail-con- 
taining variant in a lineage of organisms that yielded S. 
cereuisiae and R lactis. In  this model, N-recognin and UbcP 
of the S. cereuisiae lineage (but  not  the homologous protein 
pairs in predecessors of fission yeast and larger eukaryotes) 
coevolved in a way that resulted in a positively charged surface 
of a  domain in N-recognin accommodating the multiple Asp 
and Glu residues of the acidic tail in Ubc2. Throughout this 
coevolution, UbcP would be expected to  retain its affinities 
for other recognins (which mediate other  functions of Ubc2) 
in ways that did not depend on the presence of an acidic tail 
in Ubc2. However, the converse interpretation, in which a 
tail-bearing Ubc2 and a correspondingly adapted N-recognin 
is the  ancestral configuration, is also plausible, in  part because 
nothing is known about the  nature of selective pressures that 
could underlie a tail-related coevolution of Ubc2 and N- 
recognin in some but  not in  all species. 
Regulatory Interactions  in  the N-end Rule Pathway-The 
intact N-recognin . Ubc2 complex was shown to be required 
for an observed decrease in the level of UBRI mRNA (which 
encodes N-recognin) upon an increase in UBC2 expression. 
A  variety of evidence suggests that a decrease in  the level of 
UBRl  mRNA is brought  about by a UBC2-mediated decrease 
in its metabolic stability (see “Results”). It remains to be seen 
whether this new effect of Ubc2 is mediated by the presently 
known function of the N-recognin Ubc2 complex, i.e. by an 
N-end rule-mediated degradation of a  short-lived  protein that 
directly or indirectly stabilizes UBRl mRNA, or whether a 
proteolysis-independent  mechanism is involved. 
Expression of genes that encode interacting proteins is 
’ P. R. H. Waller and A. Varshavsky, unpublished data. 
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often coregulated to  maintain  an  appropriate  concentration 
of a multiprotein complex as well as correct stoichiometries 
of its components. The effect of UBC2 expression on  the level 
of UBRl mRNA (see “Results”)  is a likely example of such a 
regulation. The expression of S. cerevisiae genes encoding Nt- 
amidase and Arg-tRNA-protein transferase appears to be 
coregulated as well, presumably to maintain correct stoichi- 
ometry of these interacting enzymes.‘ The evidence for core- 
gulation includes the presence of common nucleotide sequence 
motifs in upstream regions of genes that encode components 
of the N-end rule pathway.6 
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